Delivery Order SPE2DB22D9316-SPE2DB25FYN92
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $2,754.30 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on May 20, 2025, for the supply of Botox 200 unit vials. The delivery order, which carries an ultimate completion date of June 11, 2025, was issued without a set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19.4K by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Botox 200 unit vials. The delivery order carries an ultimate completion date of September 16, 2025, and represents a non-set-aside competitive award. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, valued at $64.7K with an ultimate completion date of September 18, 2025, carries no set-aside designation. The award represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for BOTOX 200 Unit Vials valued at $12,937.00 by the Defense Logistics Agency (DLA) on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's Park Ridge facility. The award is issued under the company's existing...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $7,762.20 by the Defense Logistics Agency for the supply of Botox 200 unit vials. This firm fixed-price delivery order, awarded on August 25, 2025, with an ultimate completion date of September 16, 2025, represents a direct pharmaceutical supply requirement for Department of Defense healthcare facilities. The award was executed without a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $11,564.25 for Botox 100-unit vials by the Defense Logistics Agency's Medical Supply Chain division. The firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, carries no set-aside designation. This award falls under DMS Pharmaceutical Group's existing single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,234.25 for Botox 200-unit vials by the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with an ultimate completion date of October 6, 2025, and carries no set-aside designation. This award represents a discrete order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 4, 2025, by the Defense Logistics Agency (DLA) for BOTOX 200 Unit Vials with a ceiling value of $9,636.00. This firm fixed-price delivery order, which carries an ultimate completion date of August 25, 2025, represents a direct procurement without set-aside designation. The award leverages DMS Pharmaceutical Group's position as a crucial...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order valued at $2,587.40 by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Botox 200-unit vials. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, represents a discrete purchase under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $64,685 by the Defense Logistics Agency on August 26, 2025, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order is scheduled for completion by September 17, 2025, with no set-aside designation applied. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB25FYN92Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $45,905 delivery order by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, with an ultimate completion date of May 15, 2025, represents a discrete task order issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract (IDC) with the DLA valued at $500 million through November 2026. The IDC, designated SPE2DB, authorizes the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. As a established supplier in the federal pharmaceutical supply chain since 2001, DMS Pharmaceutical Group leverages its woman-owned small business status to provide critical medical supplies to military health systems without set-aside competition restrictions. The delivery order for Botox reflects the contractor's demonstrated capacity to supply specialized pharmaceutical products across diverse medical applications, from oncology treatments to injectable medications. This award underscores DMS Pharmaceutical Group's integral role in ensuring consistent pharmaceutical availability to Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.9k | 4/24/25 |